Measurement of HbA1c in multicentre diabetes trials – should blood samples be tested locally or sent to a central laboratory: an agreement analysis

BACKGROUND: Glycated haemoglobin (HbA1c) is an important outcome measure in diabetes clinical trials. For multicentre designs, HbA1c can be measured locally at participating centres or by sending blood samples to a central laboratory. This study analyses the agreement between local and central measu...

Descripción completa

Detalles Bibliográficos
Autores principales: Arch, Barbara N., Blair, Joanne, McKay, Andrew, Gregory, John W., Newland, Paul, Gamble, Carrol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078896/
https://www.ncbi.nlm.nih.gov/pubmed/27776543
http://dx.doi.org/10.1186/s13063-016-1640-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078896/
https://www.ncbi.nlm.nih.gov/pubmed/27776543
http://dx.doi.org/10.1186/s13063-016-1640-6

Ejemplares similares